CompletedNot Applicable

Superficial Cervical Plexus Block for IJCL Pain Management

United States14 participantsStarted 2022-01-15

Plain-language summary

This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who are 18 years and older, and; * Present to the Akron General Emergency Department (Main) between March 1, 2021 and December 1, 2022, and; * Require IJVC as a part of their clinical care. Exclusion Criteria: * Patients who are intubated; or * Patients who undergo CPR; or * Patients who have an allergy to lidocaine or bupivacaine; or * Patients who have a contraindication to receiving a superficial cervical plexus block such as cellulitis over Erb's point or the internal jugular vein, abnormal anatomy, or prior surgery to the area.

What they're measuring

Visual Analog Scale Rating

Timeframe: 30 minutes post central line placement

Trial details

NCT IDNCT05252832

SponsorCleveland Clinic Akron General

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-20

View on ClinicalTrials.gov More Superficial Cervical Plexus Block trials